About Sanpra Synthesis
Sanpra Synthesis is a Consumer company. Manufacturing of APIs, intermediates, and fine chemicals in India. It operates in the Consumer and Chemicals & Materials sectors. The company has 56 employees. Its Indian entity Sanpra Synthesis Private Limited reported revenue of ₹60.91 Cr. Sanpra Synthesis offers products and services including APIs and Intermediates. Its focus areas include Chemicals, Fine Chemicals, Reagents Supply and Cosmetics Ingredients.
Company details
Sanpra Synthesis is known for providing manufacturing services in Active Pharmaceutical Ingredients (APIs) and intermediates, with operations established in 2015 under the Indian Companies Act and headquartered in Hyderabad, Telangana. Commitment to global standards is demonstrated through consistent quality efforts and innovative research and development practices. Custom synthesis and contract manufacturing are offered, supplying fine chemicals and reagents to international markets, while research drives product innovation and reliability in the pharmaceutical sector.
- Employees 56
- SectorsConsumerChemicals & Materials
- Email••••••••
- Phone•••• ••••
- Legal Name Sanpra Synthesis Private Limited
- Date of Incorporation 02 Dec, 2015
- Jurisdiction Visakhapatnam, Andhra Pradesh, India
- Indian entity revenue₹60.91 Cr
FY 2025 · -5% YoY
- Indian entity net profit₹1.15 Cr
FY 2025 · 2% margin
- Indian entity EBITDA₹4.73 Cr
FY 2025 · 8% margin
- Employee Count56
Associated legal entities of Sanpra Synthesis
Sanpra Synthesis operates through Sanpra Synthesis Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sanpra Synthesis Private Limited CIN U24233AP2015PTC097822 | Active | 02 Dec 2015 | Visakhapatnam, Andhra Pradesh | ₹60.9 Cr | 56 | 4 | View details |
Products & Services of Sanpra Synthesis
Sanpra Synthesis offers a comprehensive portfolio of products and services, including APIs and Intermediates.
Manufacturing and development of Active Pharmaceutical Ingredients are carried out for global market supply
Production of advanced intermediates for pharmaceuticals and related applications is undertaken
Board of directors of Sanpra Synthesis Private Limited (Sanpra Synthesis)
Sanpra Synthesis Private Limited is the primary company behind Sanpra Synthesis. The board of Sanpra Synthesis Private Limited currently have 4 directors; the longest-serving is Appari Naga Ratna Devi, appointed in 2015. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Appari Naga Ratna Devi DIN 07331888 | Director | 02 Dec 2015 | 10 yrs 10 mo | Sanpra Synthesis Private Limited |
| Appari Ravindranath DIN 03313396 | Director | 02 Dec 2015 | 10 yrs 10 mo | Sanpra Synthesis Private Limited |
| Tippa Naga Koteswara Rao DIN 03313428 | Director | 01 Aug 2018 | 8 yrs 2 mo | Sanpra Synthesis Private Limited |
| Ramalingeswara Puli Rao DIN 05160971 | Director | 29 Sep 2022 | 4 yrs | Sanpra Synthesis Private Limited |
Financials of Sanpra Synthesis
Figures of Sanpra Synthesis Private Limited, the primary company behind Sanpra Synthesis, for FY 2025. Revenue was ₹60.91 Cr (-5% year on year). Net profit was ₹1.15 Cr (2% margin). EBITDA was ₹4.73 Cr (8% margin). Revenue has grown at a compounded annual rate of -9% over three years and +25% over five years.
- ₹60.91 CrRevenue · FY 2025 · -5% YoY
- ₹1.15 CrNet profit · 2% margin
- ₹4.73 CrEBITDA · 8% margin
- ₹9.25 CrPaid-up capital
- 56Employees (provident fund records)
- -9%Revenue CAGR, 3 years
- +25%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sanpra Synthesis Private Limited are on its company page.
Detailed financial statements for Sanpra Synthesis
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sanpra Synthesis
Sanpra Synthesis has 56 employees.
The primary company behind Sanpra Synthesis, Sanpra Synthesis Private Limited, reported revenue of ₹60.91 Cr for FY 2025, down 5% year on year.
Sanpra Synthesis is known for providing manufacturing services in Active Pharmaceutical Ingredients (APIs) and intermediates, with operations established in 2015 under the Indian Companies Act and headquartered in Hyderabad, Telangana. Commitment to global standards is demonstrated through consistent quality efforts and innovative research and development practices. Custom synthesis and contract manufacturing are offered, supplying fine chemicals and reagents to international markets, while research drives product innovation and reliability in the pharmaceutical sector.
Sanpra Synthesis offers APIs and Intermediates.
Sanpra Synthesis operates through Sanpra Synthesis Private Limited.
The legal entities of Sanpra Synthesis currently have 4 directors, including Appari Naga Ratna Devi, Ramalingeswara Puli Rao, Tippa Naga Koteswara Rao and others.